This might be explained by the fact that Asian female patients with lung cancer are more likely to have adenocarcinoma with EGFR mutation,44,45 making the disease biologically distinct and more effectively treatable with targeted therapy. The gene discussed is EGFR; the disease is adenocarcinoma.